新辅助化疗后结直肠癌肝转移的检出与活力评估:多参数PET/CT-MRI研究
该前瞻性研究纳入45例新辅助化疗后的结直肠癌肝转移患者,比较钆塞酸二钠增强联合扩散加权MRI与静脉对比增强FDG PET/CT检出转移灶的能力。40例随后手术,术中超声作为参考标准。两种方法检出率相似(P=0.61),仅FDG PET代谢参数与肿瘤活力相关,MRI的ADC与活力无关。
要点
- MRI与对比增强FDG PET/CT对结直肠癌肝转移的检出率相似(P=0.61)
- 最大TBR(r=0.33,P=0.006)和平均TBR(r=0.37,P=0.002)与肿瘤活力显著相关
- 最小ADC(r=-0.02,P=0.9)和平均ADC(r=0.01,P=0.9)与肿瘤活力无显著相关
核心结论
- 钆塞酸二钠增强联合扩散加权MRI与对比增强FDG PET/CT均可较有把握地检出结直肠癌肝转移,但新辅助化疗后仅FDG PET代谢参数与肿瘤活力相关。
研究设计与样本
- 前瞻性研究,新辅助化疗后纳入45例结直肠癌肝转移患者,均行钆塞酸二钠增强联合扩散加权MRI及对比增强FDG PET/CT。
- 40例随后接受手术,以术中超声作为结直肠癌肝转移存在的参考标准,比较各技术检出的转移灶数目。
- 对69个切除的转移灶,分析SUVmean、SUVmax、平均和最大靶本比、总病灶糖酵解、代谢肿瘤体积及平均和最小表观扩散系数与组织学肿瘤活力的相关性。
主要发现
- 术中超声发现153个结直肠癌肝转移灶,其中122个被切除。
- MRI与对比增强FDG PET/CT的检出率相似(P=0.61)。
- 新辅助化疗后术前影像上SUVmax与最小ADC呈负相关(r=-0.34,P=0.005)。
- 肿瘤活力与最大靶本比(r=0.33,P=0.006)和平均靶本比(r=0.37,P=0.002)显著相关,但与最小ADC(r=-0.02,P=0.9)和平均ADC(r=0.01,P=0.9)无关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to compare combined gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA)-enhanced and diffusion-weighted (DW) MRI with IV contrast-enhanced F-FDG PET/CT to detect and assess the viability of colorectal liver metastases (CLMs) after neoadjuvant chemotherapy (NAC). PATIENTS AND METHODS: After NAC, 45 patients with CLMs were prospectively enrolled and underwent combined Gd-EOB-DTPA-enhanced and DW-MRI and contrast-enhanced F-FDG PET/CT. Forty patients subsequently underwent surgery based on intraoperative ultrasound, which served as the reference standard for the presence of CLMs. The number of metastases detected by each technique was then compared. In 69 resected metastases, the SUVmean and SUVmax, mean and maximum target-to-background ratio (TBR), total lesion glycolysis, metabolic tumor volume, and mean and minimum apparent diffusion coefficient (ADC) were examined to identify correlations with the corresponding tumor viability (TV) determined from histological specimens. RESULTS: Intraoperative ultrasound revealed 153 CLMs, 122 of which were resected. The detection rate of MRI and contrast-enhanced F-FDG PET/CT were similar (P = 0.61). The SUVmax and minimum ADC were negatively correlated (r = -0.34, P = 0.005) on preoperative imaging after NAC. However, TV was significantly correlated with the maximum TBR (r = 0.33, P = 0.006) and mean TBR (r = 0.37, P = 0.002), but not with the minimum ADC (r = -0.02, P = 0.9) or mean ADC (r = 0.01, P = 0.9). CONCLUSIONS: Combined Gd-EOB-DTPA-enhanced and DW-MRI and contrast-enhanced F-FDG PET/CT allow confident detection of CLMs, but only F-FDG PET metrics are associated with TV after NAC.
引用
- Dunet V, Halkic N, Prior JO, et al. Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study. Clin Nucl Med. 2017. PMID: 28166142. doi:10.1097/RLU.0000000000001538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。